Introduction Magnesium sulfate is used world‐wide to treat pregnant women at imminent risk
of preterm delivery in order to protect the brain of the premature infant. Previous research …

ABSTRACT Background: Magnesium sulfate (MgSO4) can be used for the primary
prevention of cerebral palsy in preterm infants less than 37 weeks of gestational age. Aim …

Background Survival of preterm infants has improved drastically. In addition to significant
contribution to neonatal mortality, impact of prematurity among survivors may continue …

Introduction Antenatal magnesium sulfate (MgSO 4) administration has shown to be effective
in minimizing cerebral palsy and severe motor dysfunction at the age of 2 years. The aim of …

Preterm birth is still a huge problem in modern obstetrics. Because the stakes are so high,
physicians and parents are understandably anxious to do anything possible to prevent …

The aim of our study was to assess the feasibility of implementing a protocol for the use of
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …

Abstract Objective: Magnesium sulfate (MgSO4) administered to women at risk for preterm
delivery decreases the risk of cerebral palsy in their children. However, the neuroprotective …

Background Magnesium sulphate is currently recommended for neuroprotection of preterm
infants for women at risk of preterm birth at less than 30 weeks' gestation, based on high …

ContextPrenatal magnesium sulfate may reduce the risk of cerebral palsy or death in very
preterm infants. ObjectiveTo determine the effectiveness of magnesium sulfate given for …

Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …